サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571960

心臓補装具の世界市場

Cardiac Prosthetic Devices

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
心臓補装具の世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓補装具の世界市場は2030年までに119億米ドルに到達

2023年に74億米ドルと推定される心臓補装具の世界市場は、分析期間2023-2030年にCAGR 7.2%で成長し、2030年には119億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである植込み型ペースメーカーは、CAGR 7.7%を記録し、分析期間終了時には47億米ドルに達すると予測されます。体外式ペースメーカーセグメントの成長率は、分析期間中CAGR 6.8%と推定されます。

米国市場は19億米ドル、中国はCAGR10.7％で成長予測

米国の心臓補装具市場は、2023年に19億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに29億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.5％と6.4％と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の心臓補装具市場- 主要動向と促進要因のまとめ

心臓補装具とは何か、なぜ心臓ケアに不可欠なのか？

心臓補装具は、心臓の損傷または故障したコンポーネントをサポートまたは交換するために使用される医療用インプラントであり、様々な心臓疾患を持つ患者に救命ソリューションを提供します。これらの機器には、心臓弁、ペースメーカー、除細動器、補助人工心臓（VAD）などがあり、心臓の構造的疾患、不整脈、心不全の管理において極めて重要な役割を果たしています。心血管疾患（CVDs）、特に心臓弁障害と心不全の世界の罹患率の上昇に伴い、心臓補装具は現代の心臓病学において極めて重要なものとなっています。

心臓弁置換術は最も一般的に行われている心臓補装具の一つです。弁狭窄や逆流などの問題に対して、欠陥のある弁を機械的あるいは生物学的な代替品に置き換えることで対処します。ペースメーカーや植え込み型除細動器（ICD）のような機器は、異常な心臓のリズムを管理するのに役立ち、補助人工心臓は心臓移植を待つ患者や進行した心不全の患者の心臓機能をサポートするために使用されます。心血管疾患は依然として世界の死因のトップであるため、心臓補装具は罹患患者のQOLと生存率を向上させるために必要不可欠なものです。

技術の進歩は心臓補装具市場をどのように形成していますか？

技術の進歩は、機器の性能、患者の転帰、手技の成功率を向上させることにより、心臓補装具市場に革命をもたらしています。材料科学の革新は、より耐久性が高く生体適合性の高い心臓弁の開発につながった。例えば、新型の機械式弁は耐用年数が長く設計されており、再手術の必要性を減らしています。一方、生体弁は動物組織由来のものが多く、長期間の血液希釈剤を必要とせず、凝固リスクが低いです。さらに、経カテーテル的大動脈弁置換術（TAVR）などの経カテーテル的心臓弁置換術が大きな支持を得ています。TAVRは低侵襲手術であり、開心術を必要とせずに弁置換を行うことができ、回復時間と関連リスクを軽減します。リードレスペースメーカーは、小型で植え込みが容易なため、感染症やその他の合併症のリスクが少ないです。同様に、次世代ICDは、生命を脅かす不整脈をより的確に検出・治療するためのプログラミングが強化され、患者の予後を改善します。さらに、補助人工心臓の進歩により、これらの機器はより小型で信頼性が高く、進行した心不全患者の管理が容易になっています。遠隔モニタリングやワイヤレス接続などのデジタルヘルス技術の統合は、リアルタイムでの患者モニタリング、デバイス合併症の早期発見、より良い移植後ケアを可能にし、心臓補装具市場をさらに前進させています。

どのような患者とヘルスケアの動向が心臓補装具の需要を牽引していますか？

いくつかのヘルスケアと患者の動向が、心臓補装具の需要拡大を促進しています。高齢者は心血管疾患、特に心臓弁膜症や心不全にかかりやすいためです。平均寿命が延び続けるにつれて、心臓弁置換術、ペースメーカー、その他の心臓機器の必要性も高まっています。さらに、先天性心疾患や早期発症の心血管系疾患と診断された若年患者は、長期的な解決策を提供する補綴器具の進歩の恩恵を受けており、これらの器具はさまざまな年齢層の患者にとって極めて重要なものとなっています。

もう一つの重要な動向は、低侵襲手術に対する嗜好の高まりです。患者は、回復が早く、合併症が少なく、入院期間が短い治療をますます求めるようになっています。TAVR、経カテーテル僧帽弁形成術（TMVR）、低侵襲ペースメーカー植え込み術などの技術はこの需要に応えるものであり、より多くの患者が開心術に伴うリスクなしに救命処置を受けることを可能にしています。これらの手技がより多くの地域で利用できるようになったことで、心臓補装具はより多くの人々にとって利用しやすいものとなっています。

さらに、患者中心のケアへの注目の高まりとデジタルヘルスの台頭が需要に影響を与えています。患者やヘルスケアプロバイダーは、遠隔モニタリングが可能なデバイスを利用できるようになり、より良い処置後のフォローアップや個別ケアが可能になった。こうした進歩は慢性疾患の管理を改善し、病院の再入院を減らし、患者の満足度を高めるため、心臓補装具の需要をさらに押し上げます。

心臓補装具市場の成長はいくつかの要因別もたらされる

心臓補装具市場の成長は、心血管疾患の有病率の上昇、高齢化人口の増加、医療技術の進歩など、いくつかの要因によって牽引されています。主な要因の一つは、特に高齢者における心臓弁障害や不整脈の発生率の増加です。心臓弁膜症が加齢とともに一般的になるにつれ、機械的および生物学的な人工心臓弁の需要が高まっています。TAVRのような低侵襲手術は、そのリスクの低さと回復時間の早さから人気を集めており、市場拡大に大きく貢献しています。

技術の進歩も成長を促進する重要な要因の一つです。リードレスペースメーカー、拡張型ICD、小型補助人工心臓などの技術革新は、患者の予後を改善し、治療の対象となる患者の範囲を拡大しています。心臓補装具をデジタルヘルスツールと統合できるようになったことで、慢性心血管病患者のリアルタイムモニタリングとより良い管理が可能になり、これらのデバイスは患者とヘルスケアプロバイダーの双方にとってより効果的で魅力的なものとなっています。

さらに、予防ヘルスケアと早期診断への注目の高まりにより、包括的な心血管ケア戦略の一環として心臓補装具の採用が増加しています。新興国市場におけるヘルスケア・インフラの拡大も、心臓の健康に対する意識の高まりと相まって、市場に新たな機会をもたらしています。世界中のヘルスケアシステムが心血管疾患の負担増に取り組む中、先進的で耐久性に優れ、患者に優しい心臓補装具の需要は、今後も増加の一途をたどると予想されます。

調査対象企業の例（全42件）

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21436

Global Cardiac Prosthetic Devices Market to Reach US$11.9 Billion by 2030

The global market for Cardiac Prosthetic Devices estimated at US$7.4 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Implantable Pacemakers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the External Pacemakers segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 10.7% CAGR

The Cardiac Prosthetic Devices market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cardiac Prosthetic Devices Market – Key Trends & Drivers Summarized

What Are Cardiac Prosthetic Devices, and Why Are They Crucial for Cardiac Care?

Cardiac prosthetic devices are medical implants used to support or replace damaged or failing components of the heart, offering life-saving solutions for patients with various heart conditions. These devices include heart valves, pacemakers, defibrillators, and ventricular assist devices (VADs), which play a pivotal role in managing structural heart diseases, arrhythmias, and heart failure. With the rising global incidence of cardiovascular diseases (CVDs), especially heart valve disorders and heart failure, cardiac prosthetic devices have become critical in modern cardiology.

Heart valve replacements are among the most commonly used cardiac prosthetic devices. They address issues like valve stenosis or regurgitation by replacing faulty valves with mechanical or biological alternatives. Devices like pacemakers and implantable cardioverter defibrillators (ICDs) help manage abnormal heart rhythms, while VADs are used to support heart function in patients awaiting heart transplants or for those with advanced heart failure. As cardiovascular disease remains the leading cause of death worldwide, cardiac prosthetic devices are essential for improving the quality of life and survival rates of affected patients.

How Are Technological Advancements Shaping the Cardiac Prosthetic Devices Market?

Technological advancements are revolutionizing the cardiac prosthetic devices market by improving device performance, patient outcomes, and procedural success rates. Innovations in materials science have led to the development of more durable and biocompatible heart valves. For instance, newer mechanical valves are designed to last a lifetime, reducing the need for repeat surgeries, while biological valves, often derived from animal tissue, offer a lower risk of clotting without requiring long-term blood thinners. Additionally, transcatheter heart valve replacement technologies, such as transcatheter aortic valve replacement (TAVR), have gained significant traction. TAVR is a minimally invasive procedure that allows valve replacement without the need for open-heart surgery, reducing recovery time and associated risks. Leadless pacemakers, which are smaller and easier to implant, offer less risk of infection and other complications. Similarly, next-generation ICDs come with enhanced programming to better detect and treat life-threatening arrhythmias, improving patient outcomes. Furthermore, advancements in VADs are making these devices more compact, reliable, and easier to manage for patients with advanced heart failure. The integration of digital health technologies, such as remote monitoring and wireless connectivity, is enabling real-time patient monitoring, early detection of device complications, and better post-implant care, further advancing the cardiac prosthetic devices market.

What Patient and Healthcare Trends Are Driving the Demand for Cardiac Prosthetic Devices?

Several healthcare and patient trends are driving the growing demand for cardiac prosthetic devices. The aging global population is one of the primary factors, as older individuals are more susceptible to cardiovascular diseases, particularly valvular heart diseases and heart failure. As life expectancy continues to rise, the need for heart valve replacements, pacemakers, and other cardiac devices is also increasing. Additionally, younger patients diagnosed with congenital heart defects or early-onset cardiovascular conditions are benefiting from advancements in prosthetic devices that offer long-term solutions, making these devices crucial for patients across various age groups.

Another significant trend is the rising preference for minimally invasive procedures. Patients are increasingly seeking treatments that offer quicker recovery times, fewer complications, and shorter hospital stays. Technologies like TAVR, transcatheter mitral valve repair (TMVR), and minimally invasive pacemaker implantation cater to this demand, enabling more patients to undergo life-saving procedures without the risks associated with open-heart surgery. The expanding availability of these procedures in more regions is making cardiac prosthetic devices accessible to a broader population.

Moreover, the growing focus on patient-centric care and the rise of digital health are influencing demand. Patients and healthcare providers now have access to devices that allow for remote monitoring, enabling better post-procedure follow-up and personalized care. These advancements improve the management of chronic conditions, reduce hospital readmissions, and enhance patient satisfaction, further driving demand for cardiac prosthetic devices.

Growth in the Cardiac Prosthetic Devices Market Is Driven by Several Factors

Growth in the cardiac prosthetic devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing aging population, and advancements in medical technologies. One of the key drivers is the increasing incidence of heart valve disorders and arrhythmias, particularly among older adults. As heart valve disease becomes more common with age, the demand for prosthetic heart valves, both mechanical and biological, is rising. Minimally invasive procedures like TAVR are gaining popularity due to their lower risks and faster recovery times, contributing significantly to market expansion.

Technological advancements are another crucial factor driving growth. Innovations such as leadless pacemakers, enhanced ICDs, and compact VADs are improving patient outcomes and expanding the range of patients eligible for treatment. The ability to integrate cardiac prosthetic devices with digital health tools is enabling real-time monitoring and better management of patients with chronic cardiovascular conditions, making these devices more effective and appealing to both patients and healthcare providers.

Additionally, the growing focus on preventive healthcare and early diagnosis is increasing the adoption of cardiac prosthetic devices as part of comprehensive cardiovascular care strategies. The expansion of healthcare infrastructure in developing regions, coupled with increased awareness about heart health, is also creating new opportunities for the market. As healthcare systems worldwide work to address the growing burden of cardiovascular diseases, the demand for advanced, durable, and patient-friendly cardiac prosthetic devices is expected to continue its upward trajectory.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiac Prosthetic Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Material Science and Biocompatibility Enhance the Development of Cardiac Prosthetic Devices
    • Rising Global Prevalence of Heart Diseases Propels the Demand for Cardiac Prosthetics
    • Technological Innovations in Prosthetic Valves Improve Durability and Functional Outcomes
    • Increasing Adoption of Minimally Invasive Procedures Boosts Market Growth for Cardiac Prosthetics
    • Growth in Geriatric Population Worldwide Drives the Need for Advanced Cardiac Prosthetic Solutions
    • Expansion of Healthcare Infrastructure in Emerging Markets Opens New Opportunities for Cardiac Prosthetics
    • Patient-Specific Implants and Customization Using 3D Printing Technology Propel Market Innovations
    • Integration of Smart Sensors in Prosthetic Devices Enhances Post-Operative Monitoring and
    • Ethical and Legal Issues Surrounding the Use of Advanced Prosthetic Devices in Cardiology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Implantable Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for External Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Cardiac Prosthetic Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Spain 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Russia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Australia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: India 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: South Korea 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Argentina 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Brazil 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Mexico 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Iran 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Israel 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Saudi Arabia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UAE 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Africa 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030

IV. COMPETITION